US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Health Innovation Active ETF

33.86

-0.3088-0.90%

Post-market: 33.900.0399+0.12%16:10 EDT

Volume:5K

Turnover:153.07K

Market Cap:13.54M

PE:- -

High:34.24

Open:34.24

Low:33.86

Close:34.17

52wk High:34.86

52wk Low:25.79

Shares:400.00K

Float Shares:400.00K

Volume Ratio:7.80

T/O Rate:1.13%

Dividend:0.08

Dividend Rate:0.24%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

CSPC Pharma's Goserelin Extended-Release Injection Gets Clinical Trial Green Light in China

CSPC Pharma Gains Chinese Clinical Trial Approval for Goserelin Extended-Release Injection

Merck price target raised to $161 from $127 at Leerink

Genfit Targets Billion‑Dollar MASH Diagnostics Market With NISTM Blood Tests

Biogen Inc. Stock Underperforms Tuesday When Compared to Competitors

Edwards Lifesciences Corp. Stock Underperforms Tuesday When Compared to Competitors

Assembly Biosciences Exercises U.S. Profit-Share Option for Herpes Program with Gilead

Medtronic PLC Stock Outperforms Competitors Despite Losses on the Day

Gilead Sciences Inc. Stock Underperforms Tuesday When Compared to Competitors

Merck & Co. Inc. Stock Outperforms Competitors Despite Losses on the Day

Assembly Bio Highlights Phase 2 Starts for ABI-6250, GS-1179 in Pipeline Update

Protagonist Therapeutics Launches USD 300 Million Share Buyback Program

Assembly Biosciences Exercises U.S. Profit-Share Option with Gilead for Hsv Helicase-Primase Inhibitor Program

THOMSON REUTERS

Assembly Biosciences - Assembly Bio Eligible for up to $280 Mln in Milestones and Royalties Outside U.S.

THOMSON REUTERS

Assembly Biosciences - Gs-1179 Expected to Advance into Phase 2 Trial for Genital Herpes by End of 2026

THOMSON REUTERS

Assembly Biosciences - Gilead Retains Sole Right for Clinical Development and Commercialization of Hsv Hpi Program

THOMSON REUTERS

Gilead Sciences Inc Stock (GILD) Moved Down by 3.26% on Sep 8: Drivers Behind the Movement

ABL Diagnostics Delivers Surging Profits as Scale‑Up Strategy Takes Hold

Gilead Opens State-of-the-Art Research Center to Advance the Next Generation of Medicines

THOMSON REUTERS

AstraZeneca's COPD Candidate Shows Strong Results in Late-Stage Trials, Reviving a Once-Doubted Drug Target

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/BMED/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"BMED","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMED\",,,,,undefined,":{"symbol":"BMED","market":"US","secType":"STK","nameCN":"iShares Health Innovation Active ETF","latestPrice":33.8601,"timestamp":1789761600000,"preClose":34.1689,"halted":0,"volume":4504,"hourTrading":{"tag":"盘后","latestPrice":33.9,"preClose":33.8601,"latestTime":"16:10 EDT","volume":6,"amount":203.2404,"timestamp":1789762203701,"change":0.0399,"changeRate":0.001178,"amplitude":0},"delay":0,"changeRate":-0.009037458039328101,"floatShares":400000,"shares":400000,"eps":0,"marketStatus":"Closed","change":-0.3088,"latestTime":"09-18 16:00:00 EDT","open":34.24,"high":34.24,"low":33.8601,"amount":153073,"amplitude":0.011118,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":5,"adr":0,"exchange":"ARCA","adjPreClose":34.1689,"sharesOutstanding":360000,"nav":34.171902,"aum":13668760.8,"dividendRate":0.002422,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":33.9,"preClose":33.8601,"latestTime":"16:10 EDT","volume":6,"amount":203.2404,"timestamp":1789762203701,"change":0.0399,"changeRate":0.001178,"amplitude":0},"volumeRatio":7.797782,"impliedVol":0.2698,"impliedVolPercentile":0.7331},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMED\",,,,,undefined,":{"symbol":"BMED","floatShares":400000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":7.797782,"shares":400000,"dividePrice":0.082,"high":34.24,"amplitude":0.011118,"preClose":34.1689,"low":33.8601,"week52Low":25.794,"pbRate":"--","week52High":34.86,"institutionHeld":0,"latestPrice":33.8601,"eps":0,"divideRate":0.002422,"volume":4504,"delay":0,"ttmEps":0,"open":34.24,"prevYearClose":30.32,"prevWeekClose":32.965,"prevMonthClose":33.8091,"prevQuarterClose":30.62,"fiveDayClose":32.965,"twentyDayClose":34.061,"sixtyDayClose":29.4033},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BMED\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"BMED","amount":0.08118,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"iShares Health Innovation Active ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2023-12-20","symbol":"BMED","amount":0.007207,"announcedDate":"2023-12-20","type":"dividend","market":"US","newRecordDate":"2023-12-21","defaultRemindTime":1703082600000,"name":"BlackRock Future Health ETF","recordDate":"2023-12-27","payableDate":"2023-12-21","currency":"USD","dateTimestamp":1703048400000,"payDate":"2023-12-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BMED\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-27","value":0.007207,"currency":"USD"},{"executeDate":"2026-06-15","recordDate":"2026-06-15","paymentDate":"2026-06-18","value":0.08118,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BMED\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BMED\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1151768833","title":"CSPC Pharma's Goserelin Extended-Release Injection Gets Clinical Trial Green Light in China","url":"https://stock-news.laohu8.com/highlight/detail?id=1151768833","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151768833?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:12","pubTimestamp":1788948739,"startTime":"0","endTime":"0","summary":"CSPC PHARMA (01093) has announced that its self-developed gonadotropin-releasing hormone (GnRH) receptor agonist, Goserelin Extended-Release Injection (SYH9102 Injection), has received approval from...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBJ","IE0008369823.USD","BMED","IE00B543WZ88.USD","LU0326950275.SGD","LU1807302812.USD","BK1521","BK1191","LU1951186391.HKD","LU1960683339.HKD","IBBQ","IE0008368742.USD","IE00B5MMRT66.SGD","IE00BZ08YR35.GBP","LU0314109678.HKD","LU0501845795.SGD","KURE","LU1813983027.USD","MDTX","PSYK","LU1226288253.USD","LU0067412154.USD","LU0315179316.USD","LU0072913022.USD","LU0880133367.SGD","01093","LU1152091168.USD","LU1226288170.HKD","BK1515","LU0140636845.USD","IE00BZ08YT58.USD","LU1226287792.SGD","IE00B031HY20.USD","LU1328277881.USD","LU1993786604.SGD","HK0000165453.HKD","LU1152091754.HKD","LU2039709279.SGD","IE00BZ08YS42.EUR","SG9999004220.SGD","LU1008478684.HKD","LU1226287875.USD","LU1226287529.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100647125","title":"CSPC Pharma Gains Chinese Clinical Trial Approval for Goserelin Extended-Release Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=1100647125","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100647125?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:12","pubTimestamp":1788948739,"startTime":"0","endTime":"0","summary":"CSPC PHARMA (01093) has announced that its self-developed gonadotropin-releasing hormone (GnRH) receptor agonist, Goserelin Extended-Release Injection (SYH9102 Injection), has received approval from...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBJ","LU0072913022.USD","LU1960683339.HKD","LU1152091168.USD","LU0501845795.SGD","IE00BZ08YR35.GBP","BK1515","LU1226287875.USD","HK0000165453.HKD","IE00BZ08YS42.EUR","LU1813983027.USD","LU0067412154.USD","LU1951186391.HKD","LU0140636845.USD","LU1993786604.SGD","PSYK","LU0326950275.SGD","IE00BZ08YT58.USD","IE0008368742.USD","BMED","LU1008478684.HKD","01093","LU1807302812.USD","LU1226288253.USD","IBBQ","LU1226288170.HKD","BK1191","LU1226287529.USD","LU1226287792.SGD","IE00B543WZ88.USD","IE0008369823.USD","BK1521","IE00B031HY20.USD","MDTX","LU0880133367.SGD","LU1152091754.HKD","LU2039709279.SGD","LU0315179316.USD","KURE","SG9999004220.SGD","LU0314109678.HKD","IE00B5MMRT66.SGD","LU1328277881.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666450584","title":"Merck price target raised to $161 from $127 at Leerink","url":"https://stock-news.laohu8.com/highlight/detail?id=2666450584","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666450584?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:10","pubTimestamp":1788948612,"startTime":"0","endTime":"0","summary":"Leerink raised the firm’s price target on Merck (MRK) to $161 from $127 and keeps an Outperform rating on the shares. Published first on TheFly – t...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/merck-price-target-raised-to-161-from-127-at-leerink-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/merck-price-target-raised-to-161-from-127-at-leerink-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4559","LU1032466523.USD","SG9999014542.SGD","LU1116320737.USD","LU0868494617.USD","LU1917777945.USD","LU1934455194.USD","MRK","LU2125909593.SGD","SG9999015341.SGD","LU2491050154.USD","LU1974910355.USD","LU1201861249.SGD","IXJ","LU1057294990.SGD","LU2433249047.HKD","LU2023250504.SGD","BK4550","LU2324357040.USD","LU0122379950.USD","LU2361044949.HKD","TRUH","SG9999001176.USD","LU1023059063.AUD","LU2023250843.SGD","BK4588","IE000M9KFDE8.USD","LU1066051811.HKD","IE00BJJMRZ35.SGD","LU0265550359.USD","LU2491050071.SGD","LU0265550946.USD","VHT","SG9999002232.USD","LU0980610538.SGD","LU0106261372.USD","GDOC","LU1571399168.USD","PAWZ","SG9999002224.SGD","LU1989772840.SGD","RXL","IE00BLSP4239.USD","LU0965509283.SGD","LU0234572021.USD","IHE","LU0208291251.USD","LU2361044865.SGD","IE00BFTCPJ56.SGD","SG9999001176.SGD","LU1093756325.SGD","LU2125909247.SGD","SG9999013999.USD","LU0432979614.USD","LU1035773651.USD","BK4585","LU0320765489.SGD","LU1066051498.USD","LU2112291526.USD","LU0203347892.USD","IE00BBT3K403.USD","HRTS","PPH","SG9999014575.USD","IE00B1BXHZ80.USD","BK4534","LU2468319806.SGD","IE00B2B36J28.USD","SG9999014567.USD","LU0124676726.USD","IE00BLSP4452.SGD","LU1983299246.USD","LU1037948541.HKD","LU0823416689.USD","LU1934455277.USD","IE00BN8TJ469.HKD","LU0965509010.AUD","LU0477156953.USD","LU1934455863.HKD","IE00BJT1NW94.SGD","LU0648001328.SGD","FHLC","LU0942090050.USD","FTXH","LU0098860793.USD","LU0203345920.USD","IYH","LU1699723380.USD","LU0985320562.USD","LU1291159041.SGD","LU1929549753.HKD","LU2491049909.HKD","LU1037948897.HKD","IE0009355771.USD","LU0130102774.USD","LU1941712264.USD","LU1061106388.HKD","LU0859254822.USD","LU0130517989.USD","SGXZ57979304.SGD","LU2106854487.HKD","LU1989771016.USD","IE0002141913.USD","LU1941712348.USD","LU1116320901.HKD","BK4516","LU1923622614.USD","LU1069347547.HKD","SG9999001440.SGD","LU1585245621.USD","LU1066053197.SGD","LU1989772923.USD","LU1162221912.USD","XLV","LU0238689110.USD","LU2125154778.USD","LU2357627491.SGD","LU0070302665.USD","IE00BSNM7G36.USD","LU0965509101.SGD","LU0320765646.SGD","BMED","SG9999014559.SGD","LU0266013472.USD","LU0868494708.USD","LU0965508806.USD","LU2125154935.USD","LU0289739699.SGD","LU0861579265.USD","LU2461242641.AUD","IE00B4R5TH58.HKD","LU2360032135.SGD","LU0058720904.USD","LU1093756168.USD","LU0689626769.HKD","JDOC","LU0211331839.USD","LU0006306889.USD","SG9999015358.SGD","LU2089984988.USD","BK4533","LU1066051225.USD","LU2361045086.USD","LU1430594728.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666307256","title":"Genfit Targets Billion‑Dollar MASH Diagnostics Market With NISTM Blood Tests","url":"https://stock-news.laohu8.com/highlight/detail?id=2666307256","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666307256?lang=en_us&edition=fundamental","pubTime":"2026-09-09 14:17","pubTimestamp":1788934629,"startTime":"0","endTime":"0","summary":"Genfit ( ($FR:GNFT) ) has issued an announcement. Genfit is sharpening its focus on non‑invasive diagnostics for MASLD and MASH, aiming to replace ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/genfit-targets-billiondollar-mash-diagnostics-market-with-nistm-blood-tests?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/genfit-targets-billiondollar-mash-diagnostics-market-with-nistm-blood-tests?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BMED","GNFTF","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666237038","title":"Biogen Inc. Stock Underperforms Tuesday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2666237038","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666237038?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:58","pubTimestamp":1788901080,"startTime":"0","endTime":"0","summary":"DJ Biogen Inc. Stock Underperforms Tuesday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Biogen Inc.  slipped 3.77% to $212.50 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index  falling 0.58% to 7,673.52 and Dow Jones Industrial Average  falling 1.18% to 52,786.07.This was the stock's second consecutive day of losses.Biogen Inc. closed 5.89% short of its 52-week high of $225.80, which the company reached on September 3rd.The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson  fell 2.22% to $269.12, Pfizer Inc.  fell 2.32% to $27.79, and AbbVie Inc.  fell 2.99% to $248.78.Trading volume  remained 492,227 below its 50-day average volume of 1.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 8, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z9Z06.USD","BIIB","BK4585","LU0109394709.USD","BMED","PBE","LU0320765992.SGD","BK4532","IE00B894F039.SGD","BK4588","IE00B19Z9P08.USD","BK4139","LU0234570918.USD","LU0889565916.HKD","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666377002","title":"Edwards Lifesciences Corp. Stock Underperforms Tuesday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2666377002","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666377002?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:50","pubTimestamp":1788900600,"startTime":"0","endTime":"0","summary":"DJ Edwards Lifesciences Corp. Stock Underperforms Tuesday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Edwards Lifesciences Corp.  slipped 3.54% to $86.72 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index  falling 0.58% to 7,673.52 and Dow Jones Industrial Average  falling 1.18% to 52,786.07.Edwards Lifesciences Corp. closed 9.94% short of its 52-week high of $96.29, which the company achieved on July 7th.The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Abbott Laboratories  fell 2.59% to $105.52, Medtronic PLC  fell 1.89% to $92.39, and Stryker Corp.  fell 8.81% to $276.43.Data source: Dow Jones Market Data, FactSet. Data compiled September 8, 2026.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1721429741.USD","LU0345774391.USD","SG9999002232.USD","LU0162691827.USD","BK4567","BMED","LU0122379950.USD","SG9999001176.SGD","LU0345774631.USD","SG9999004303.SGD","BK4566","LU0314106906.USD","IE00BQXX3C00.GBP","SG9999013999.USD","IE00BDGV0183.EUR","LU2506951958.HKD","MDT","LU0006306889.USD","LU1791710400.SGD","IE00B42XCP33.USD","LU2089283258.USD","LU1116320901.HKD","SYK","LU0496365809.HKD","ABT","LU0320765489.SGD","LU2404859741.USD","LU0690374615.EUR","LU2028103732.USD","BK4581","IE00BFTCPJ56.SGD","LU1244550221.USD","LU1670627923.USD","LU0158827781.USD","IHI","IE00B3PB1722.GBP","BK4588","LU0823416689.USD","AGNG","LU2111349929.HKD","PJP","LU2271345857.HKD","EW","LU1116320737.USD","LU2023251221.USD","TMED","LU1914381329.SGD","BK4082","IE00BQXX3F31.USD","LU1989763690.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666377026","title":"Assembly Biosciences Exercises U.S. Profit-Share Option for Herpes Program with Gilead","url":"https://stock-news.laohu8.com/highlight/detail?id=2666377026","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666377026?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:49","pubTimestamp":1788900540,"startTime":"0","endTime":"0","summary":"Assembly Biosciences said it exercised a profit-sharing option for the development of a herpes treatment under its collaboration agreement with Gilead Sciences.The biotechnology company said it will s","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKVL7J92.USD","LU1061106388.HKD","LU2468319806.SGD","BIB","SG9999015952.SGD","LU1585245621.USD","LU0823416689.USD","LU0320765992.SGD","LU0859254822.USD","IBBQ","LU1934455277.USD","IE0002270589.USD","MEDI","LU0889565916.HKD","SG9999015978.USD","IBB","IE00BSNM7G36.USD","BK4583","LU1037948541.HKD","LU1674673428.USD","BK4532","LU0965508806.USD","BK4566","GILD","LU0965509101.SGD","LU2087621335.USD","LU1037948897.HKD","BK4588","LU1839511570.USD","BBH","LU2324357040.USD","LU1066051498.USD","TBXU","LU1674673691.USD","BMED","LU1057294990.SGD","LU0109394709.USD","TMED","BK4550","BK4568","LU2357627491.SGD","BK4139","LU0861579265.USD","LU1066053197.SGD","IE00B3T34201.USD","LU0058720904.USD","LU0122379950.USD","SG9999015945.SGD","ASMB","LU0234570918.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666243377","title":"Medtronic PLC Stock Outperforms Competitors Despite Losses on the Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2666243377","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666243377?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:38","pubTimestamp":1788899880,"startTime":"0","endTime":"0","summary":"DJ Medtronic PLC Stock Outperforms Competitors Despite Losses On The DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Medtronic PLC  slid 1.89% to $92.39 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index  falling 0.58% to 7,673.52 and Dow Jones Industrial Average  falling 1.18% to 52,786.07.The stock's fall snapped a four-day winning streak.Medtronic PLC closed 13.11% below its 52-week high of $106.33, which the company reached on November 26th.The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson  fell 2.22% to $269.12, Danaher Corp.  fell 1.17% to $205.23, and Abbott Laboratories  fell 2.59% to $105.52.Trading volume  eclipsed its 50-day average volume of 7.8 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 8, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IHI","IHE","LU2063271972.USD","LU1061106388.HKD","LU0289960550.SGD","XLV","FTXH","LU0234572021.USD","LU1670627923.USD","LU1989763690.USD","IYH","LU0122379950.USD","LU1894683348.USD","RXL","LU2125910179.SGD","IE00BN8TJ469.HKD","LU0496365809.HKD","VHT","LU1280957306.USD","GDOC","LU2129689431.USD","MEDX","BK4534","JNJ","IE00BJT1NW94.SGD","SG9999002232.USD","JDOC","BK4581","DHR","MDT","LU0320765059.SGD","IE000WAW04H5.SGD","LU1261432733.SGD","LU1721429741.USD","TRUH","LU0158827781.USD","LU1023059063.AUD","TMED","PJP","FHLC","IE00B3T34201.USD","IXJ","LU0162691827.USD","FMED","LU0170899867.USD","ABT","LU1791710400.SGD","LU2211814178.USD","SG9999013999.USD","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666416377","title":"Gilead Sciences Inc. Stock Underperforms Tuesday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2666416377","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666416377?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:35","pubTimestamp":1788899700,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Underperforms Tuesday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  slid 2.88% to $146.64 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index  falling 0.58% to 7,673.52 and Dow Jones Industrial Average  falling 1.18% to 52,786.07.This was the stock's second consecutive day of losses.Gilead Sciences Inc. closed 6.77% below its 52-week high of $157.29, which the company reached on February 11th.The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson  fell 2.22% to $269.12, Pfizer Inc.  fell 2.32% to $27.79, and Abbott Laboratories  fell 2.59% to $105.52.Trading volume  remained 673,543 below its 50-day average volume of 6.7 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 8, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823416689.USD","BK4139","LU0234570918.USD","SG9999015952.SGD","LU1061106388.HKD","LU0114720955.EUR","SG9999015945.SGD","BK4550","SG9999015978.USD","LU0058720904.USD","BK4588","LU1066051498.USD","LU1037948541.HKD","LU1037948897.HKD","LU0861579265.USD","IBBQ","LU1057294990.SGD","LU1934455277.USD","SG9999015986.USD","LU2112291526.USD","TMED","IE00B3T34201.USD","LU1066053197.SGD","BBH","LU2087621335.USD","LU0965509283.SGD","LU0965509101.SGD","IE00B7SZLL34.SGD","LU1674673428.USD","BK4585","LU0122379950.USD","LU1571399168.USD","LU0965508806.USD","TBXU","IE00B19Z3581.USD","BK4583","BMED","IBB","LU0109394709.USD","LU0289739699.SGD","LU1585245621.USD","LU1674673691.USD","LU1934455863.HKD","IE0002270589.USD","LU0859254822.USD","IE00B19Z3B42.SGD","LU0965509010.AUD","BK4578","LU2089984988.USD","LU2468319806.SGD","BK4568","BK4532","LU2357627491.SGD","LU1430594728.SGD","LU1023059063.AUD","LU1778281490.HKD","IE00BSNM7G36.USD","LU1934455194.USD","GILD","MEDI","LU0320765992.SGD","LU0889565916.HKD","LU2324357040.USD","IE00BZ1G4Q59.USD","BK4566","BIB","LU0882574055.USD","LU1839511570.USD","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666104377","title":"Merck & Co. Inc. Stock Outperforms Competitors Despite Losses on the Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2666104377","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666104377?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:33","pubTimestamp":1788899580,"startTime":"0","endTime":"0","summary":"DJ Merck & Co. Inc. Stock Outperforms Competitors Despite Losses On The DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Merck & Co. Inc.  slipped 1.24% to $148.46 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index  falling 0.58% to 7,673.52 and Dow Jones Industrial Average  falling 1.18% to 52,786.07.This was the stock's second consecutive day of losses.Merck & Co. Inc. closed 5.39% short of its 52-week high of $156.92, which the company reached on August 25th.Despite its losses, the stock outperformed some of its competitors Tuesday, as Johnson & Johnson  fell 2.22% to $269.12, Pfizer Inc.  fell 2.32% to $27.79, and Eli Lilly & Co.  fell 2.21% to $1,123.91.Trading volume  eclipsed its 50-day average volume of 9.9 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 8, 2026.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2361045086.USD","LU0965509101.SGD","LU1023059063.AUD","LU0859254822.USD","LU1037948541.HKD","IE0002141913.USD","LU0320765489.SGD","LU0238689110.USD","LU0985320562.USD","LU0106261372.USD","LU1035773651.USD","LU0265550359.USD","LU1923622614.USD","LU2361044949.HKD","PPH","LU1291159041.SGD","LU2491050154.USD","BK4533","BK4585","LU1989772840.SGD","LU0477156953.USD","LU2112291526.USD","LU0234572021.USD","LU2125909247.SGD","BK4534","SGXZ57979304.SGD","BK4559","LU0868494617.USD","LU1430594728.SGD","BMED","LU0868494708.USD","LU0122379950.USD","BK4550","IHE","LU1941712348.USD","LU0965508806.USD","LU0130102774.USD","RXL","IE00BBT3K403.USD","LU1066051225.USD","LU2023250843.SGD","SG9999001176.USD","IE00BFTCPJ56.SGD","FHLC","LU0070302665.USD","LU1061106388.HKD","LU1201861249.SGD","IE00BLSP4452.SGD","LU0208291251.USD","VHT","SG9999015341.SGD","LU2433249047.HKD","LU1941712264.USD","IE00BN8TJ469.HKD","LU0006306889.USD","SG9999014575.USD","SG9999014542.SGD","LU0058720904.USD","LU0965509283.SGD","LU1093756325.SGD","LU1057294990.SGD","LU1934455194.USD","SG9999015358.SGD","LU0265550946.USD","LU1929549753.HKD","HRTS","JDOC","LU0320765646.SGD","IE00BJJMRZ35.SGD","LU0130517989.USD","LU1989772923.USD","LU1066053197.SGD","LU1116320901.HKD","SG9999002232.USD","XLV","LU1917777945.USD","LU2461242641.AUD","LU2491049909.HKD","LU0980610538.SGD","LU1162221912.USD","LU2125909593.SGD","LU0203345920.USD","FTXH","IE00B1BXHZ80.USD","LU1974910355.USD","SG9999001440.SGD","LU1069347547.HKD","IE00BLSP4239.USD","LU0203347892.USD","GDOC","LU0289739699.SGD","LU2125154778.USD","LU0266013472.USD","LU1066051811.HKD","LU1934455863.HKD","LU2361044865.SGD","LU2491050071.SGD","BK4588","LU2468319806.SGD","LU2089984988.USD","LU2324357040.USD","LU0942090050.USD","LU1066051498.USD","PAWZ","IYH","LU1093756168.USD","LU2360032135.SGD","IE0009355771.USD","LU2023250504.SGD","SG9999002224.SGD","IE00B2B36J28.USD","BK4516","IXJ","LU1037948897.HKD","SG9999001176.SGD","LU2106854487.HKD","LU0098860793.USD","LU0124676726.USD","IE00B4R5TH58.HKD","LU0648001328.SGD","IE00BJT1NW94.SGD","SG9999013999.USD","IE000M9KFDE8.USD","LU1585245621.USD","LU1699723380.USD","LU0432979614.USD","LU1989771016.USD","LU0689626769.HKD","LU1032466523.USD","IE00BSNM7G36.USD","SG9999014567.USD","LU2357627491.SGD","LU0965509010.AUD","SG9999014559.SGD","TRUH","LU0823416689.USD","MRK","LU1934455277.USD","LU1571399168.USD","LU0211331839.USD","LU0861579265.USD","BK4007","LU1116320737.USD","LU2125154935.USD","LU1983299246.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666377856","title":"Assembly Bio Highlights Phase 2 Starts for ABI-6250, GS-1179 in Pipeline Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2666377856","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666377856?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:08","pubTimestamp":1788898126,"startTime":"0","endTime":"0","summary":"Assembly Bio highlights Phase 2 starts for ABI-6250, GS-1179 in pipeline updateAssembly Biosciences outlined multiple Phase 2 starts across its portfolio in 2026 to early 2027, led by ABI-6250 in live","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL58BQBh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1674673691.USD","LU1023059063.AUD","LU2089984988.USD","LU0058720904.USD","LU1571399168.USD","IE0002270589.USD","BK4583","LU2112291526.USD","SG9999015978.USD","IE00BKVL7J92.USD","LU1934455863.HKD","BIB","MEDI","IBB","LU1778281490.HKD","LU2324357040.USD","LU0965509283.SGD","LU0109394709.USD","LU0320765992.SGD","BK4585","GILD","IBBQ","SG9999015952.SGD","IE00B7SZLL34.SGD","TBXU","LU0234570918.USD","LU0965509101.SGD","LU0289739699.SGD","BK4566","BBH","BMED","IE00BZ1G4Q59.USD","LU1066053197.SGD","LU0965508806.USD","BK4568","LU0861579265.USD","LU1934455277.USD","SG9999015986.USD","IE00BSNM7G36.USD","LU0889565916.HKD","ASMB","TMED","IE00B3T34201.USD","LU1037948897.HKD","LU2357627491.SGD","BK4588","LU1674673428.USD","LU2468319806.SGD","LU1585245621.USD","LU1037948541.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666031372","title":"Protagonist Therapeutics Launches USD 300 Million Share Buyback Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2666031372","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666031372?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:05","pubTimestamp":1788897932,"startTime":"0","endTime":"0","summary":"Protagonist Therapeutics launches USD 300 million share buyback programProtagonist Therapeutics launched a share repurchase program for up to USD 300 million of outstanding common stock.Funding planne","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDLc74SRP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1718418525.SGD","BK4007","IE00BFXG1179.USD","RXL","SGXZ80539844.SGD","LU0058720904.USD","BK4588","IHE","LU0683600562.USD","IYH","IE0009355771.USD","LU2487616109.SGD","LU1057294990.SGD","SG9999001176.SGD","LU1032955483.USD","PJP","XLV","LU1506573853.SGD","LU2750360641.GBP","MEDX","SG9999001440.SGD","LU1551013342.USD","BK4504","FTXH","IXJ","IE0002141913.USD","BMED","LU1145028129.USD","IE00B19Z3B42.SGD","JDOC","LU2468319806.SGD","BK4533","IE00BDGV0183.EUR","LU1244550221.USD","FHLC","JNJ","LU2430703095.HKD","PTGX","LU1778281490.HKD","IE00B4R5TH58.HKD","GDOC","LU1066051225.USD","IE00B42XCP33.USD","LU1267930813.SGD","LU0689472784.USD","TRUH","VHT","IE00BGHQF631.EUR","LU0820562030.AUD","LU2602419157.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666937221","title":"Assembly Biosciences Exercises U.S. Profit-Share Option with Gilead for Hsv Helicase-Primase Inhibitor Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2666937221","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666937221?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:00","pubTimestamp":1788897600,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA4XVZNR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0823416689.USD","LU0234570918.USD","SG9999015952.SGD","LU1061106388.HKD","SG9999015945.SGD","BK4550","SG9999015978.USD","LU0058720904.USD","BK4588","LU1037948541.HKD","IBBQ","LU1934455277.USD","SG9999015986.USD","TMED","IE00B3T34201.USD","BBH","LU0965509283.SGD","LU1674673428.USD","LU0122379950.USD","TBXU","ASMB","IE00B19Z3581.USD","LU0109394709.USD","BMED","IBB","LU0289739699.SGD","LU1585245621.USD","LU1674673691.USD","LU1934455863.HKD","IE0002270589.USD","LU0859254822.USD","IE00B19Z3B42.SGD","LU0965509010.AUD","BK4578","LU2089984988.USD","LU2468319806.SGD","LU2357627491.SGD","LU1430594728.SGD","LU1023059063.AUD","LU1778281490.HKD","LU1934455194.USD","MEDI","GILD","LU0320765992.SGD","LU0889565916.HKD","IE00BZ1G4Q59.USD","BK4566","BIB","LU1839511570.USD","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666437220","title":"Assembly Biosciences - Assembly Bio Eligible for up to $280 Mln in Milestones and Royalties Outside U.S.","url":"https://stock-news.laohu8.com/highlight/detail?id=2666437220","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666437220?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:00","pubTimestamp":1788897600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA4XVZNR:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BBH","LU1934455277.USD","LU2468319806.SGD","BK4583","TBXU","LU0058720904.USD","LU1571399168.USD","SG9999015978.USD","LU1430594728.SGD","LU1585245621.USD","IE00B19Z3B42.SGD","IE00B19Z3581.USD","LU0965509101.SGD","IE00BZ1G4Q59.USD","LU2089984988.USD","TMED","IE00BKVL7J92.USD","LU2112291526.USD","LU0889565916.HKD","LU1023059063.AUD","LU0882574055.USD","LU1674673428.USD","MEDI","LU0109394709.USD","LU1066053197.SGD","LU1839511570.USD","LU1061106388.HKD","ASMB","BK4578","GILD","IBBQ","LU0965509283.SGD","IBB","LU0114720955.EUR","SG9999015952.SGD","IE00B7SZLL34.SGD","LU1934455194.USD","LU0234570918.USD","BK4588","BIB","BK4550","BK4532","BMED","LU2324357040.USD","LU1037948897.HKD","IE00B3T34201.USD","BK4139","BK4568","LU1934455863.HKD","LU1066051498.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666372203","title":"Assembly Biosciences - Gs-1179 Expected to Advance into Phase 2 Trial for Genital Herpes by End of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2666372203","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666372203?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:00","pubTimestamp":1788897600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA4XVZNR:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0234570918.USD","LU0965509283.SGD","LU1674673428.USD","IE00BSNM7G36.USD","SG9999015978.USD","ASMB","IE00BKVL7J92.USD","LU1037948897.HKD","BK4568","IE00B7SZLL34.SGD","TMED","SG9999015986.USD","LU0965508806.USD","LU1839511570.USD","TBXU","BIB","LU1934455277.USD","BK4532","LU2324357040.USD","LU2112291526.USD","LU1934455863.HKD","LU2087621335.USD","LU1037948541.HKD","LU1430594728.SGD","BK4588","GILD","LU1934455194.USD","BK4550","LU1571399168.USD","IE00B19Z3B42.SGD","LU0882574055.USD","LU1066051498.USD","LU1674673691.USD","LU0289739699.SGD","BBH","LU2089984988.USD","IE0002270589.USD","LU0109394709.USD","BMED","LU1057294990.SGD","LU0823416689.USD","LU0859254822.USD","MEDI","IBBQ","LU2468319806.SGD","BK4139","LU0965509010.AUD","BK4585","LU0320765992.SGD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666216372","title":"Assembly Biosciences - Gilead Retains Sole Right for Clinical Development and Commercialization of Hsv Hpi Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2666216372","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666216372?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:00","pubTimestamp":1788897600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA4XVZNR:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0122379950.USD","LU1066053197.SGD","MEDI","LU2112291526.USD","BK4566","LU0882574055.USD","IBBQ","IE00BKVL7J92.USD","LU0114720955.EUR","LU1674673691.USD","LU1430594728.SGD","BIB","BK4578","LU0889565916.HKD","LU0965509283.SGD","IE0002270589.USD","LU1934455277.USD","BK4550","BBH","LU0058720904.USD","LU1057294990.SGD","LU1674673428.USD","LU1839511570.USD","LU2468319806.SGD","LU1585245621.USD","BK4532","BMED","IE00BSNM7G36.USD","TMED","BK4139","LU1037948897.HKD","LU1934455863.HKD","LU0861579265.USD","GILD","SG9999015978.USD","ASMB","LU0109394709.USD","IBB","TBXU","LU0859254822.USD","SG9999015986.USD","LU0234570918.USD","LU1934455194.USD","LU0320765992.SGD","BK4585","LU0965509010.AUD","BK4583","SG9999015945.SGD","LU2324357040.USD","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666374571","title":"Gilead Sciences Inc Stock (GILD) Moved Down by 3.26% on Sep 8: Drivers Behind the Movement","url":"https://stock-news.laohu8.com/highlight/detail?id=2666374571","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666374571?lang=en_us&edition=fundamental","pubTime":"2026-09-09 01:15","pubTimestamp":1788887735,"startTime":"0","endTime":"0","summary":"• Gilead pulled back due to profit-taking following a sustained multi-month rally.\n• Strong second-quarter revenue was driven by flagship HIV and Trodelvy franchises.\n• Analysts maintain Buy ratings with an average price target of $157.79.","market":"fut","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262156548-market-movers-gild-20260908","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2357627491.SGD","IE00B19Z3581.USD","BIB","IE00B19Z3B42.SGD","LU0861579265.USD","LU0965509101.SGD","LU1585245621.USD","LU0859254822.USD","LU2324357040.USD","LU0823416689.USD","GILD","LU0965509283.SGD","BK4550","LU0320765992.SGD","TMED","LU1066053197.SGD","TBXU","LU0965509010.AUD","BMED","LU1430594728.SGD","LU0114720955.EUR","SG9999015945.SGD","LU0889565916.HKD","LU1674673691.USD","LU1023059063.AUD","LU1674673428.USD","IE00B3T34201.USD","LU2087621335.USD","LU2089984988.USD","IE00B7SZLL34.SGD","BK4532","BK4578","BK4139","LU0882574055.USD","SG9999015978.USD","LU1066051498.USD","IE00BZ1G4Q59.USD","LU1839511570.USD","IE0002270589.USD","LU1934455863.HKD","IE00BKVL7J92.USD","LU2112291526.USD","LU0122379950.USD","LU1778281490.HKD","MEDI","SG9999015952.SGD","SG9999015986.USD","LU1037948541.HKD","BK4583","LU1061106388.HKD","LU2468319806.SGD","LU0234570918.USD","LU1037948897.HKD","IBBQ","LU1057294990.SGD","BK4566","LU0965508806.USD","BBH","BK4585","LU0289739699.SGD","LU1571399168.USD","IE00BSNM7G36.USD","LU1934455194.USD","LU0109394709.USD","LU1934455277.USD","BK4568","BK4588","LU0058720904.USD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666374809","title":"ABL Diagnostics Delivers Surging Profits as Scale‑Up Strategy Takes Hold","url":"https://stock-news.laohu8.com/highlight/detail?id=2666374809","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666374809?lang=en_us&edition=fundamental","pubTime":"2026-09-09 01:05","pubTimestamp":1788887115,"startTime":"0","endTime":"0","summary":"The latest announcement is out from ABL Diagnostics SA ( ($FR:ABLD) ). ABL Diagnostics SA, a molecular diagnostics and healthcare software speciali...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/abl-diagnostics-delivers-surging-profits-as-scaleup-strategy-takes-hold?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/abl-diagnostics-delivers-surging-profits-as-scaleup-strategy-takes-hold?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EKG","GNMX","HEAL","VGT","QQH","VHT","BK4585","HELX","BMED","IGM","CGCV","ABLD","IXJ","NOBL","TCAF","BK4588","BK4550","HTEC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666717963","title":"Gilead Opens State-of-the-Art Research Center to Advance the Next Generation of Medicines","url":"https://stock-news.laohu8.com/highlight/detail?id=2666717963","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666717963?lang=en_us&edition=fundamental","pubTime":"2026-09-09 01:00","pubTimestamp":1788886800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA5WKCFL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4532","LU0234570918.USD","LU2357627491.SGD","IE00BKVL7J92.USD","BIB","LU2089984988.USD","LU0122379950.USD","IE00BZ1G4Q59.USD","LU0289739699.SGD","BK4585","IBBQ","LU0320765992.SGD","LU1934455194.USD","LU1839511570.USD","LU0965509283.SGD","LU1066053197.SGD","BK4566","LU2112291526.USD","LU0965508806.USD","BK4550","SG9999015986.USD","BK4583","LU1674673428.USD","LU2324357040.USD","LU2468319806.SGD","BK4578","TMED","IE00B19Z3581.USD","LU1037948897.HKD","IBB","LU0823416689.USD","LU1023059063.AUD","LU1057294990.SGD","LU0882574055.USD","IE00B7SZLL34.SGD","BBH","IE00B3T34201.USD","GILD","BMED","IE0002270589.USD","LU1585245621.USD","TBXU","LU1934455863.HKD","LU0859254822.USD","LU1066051498.USD","LU2087621335.USD","IE00BSNM7G36.USD","LU1778281490.HKD","MEDI","LU1674673691.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112998208","title":"AstraZeneca's COPD Candidate Shows Strong Results in Late-Stage Trials, Reviving a Once-Doubted Drug Target","url":"https://stock-news.laohu8.com/highlight/detail?id=1112998208","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112998208?lang=en_us&edition=fundamental","pubTime":"2026-09-08 21:53","pubTimestamp":1788875623,"startTime":"0","endTime":"0","summary":"AstraZeneca has unveiled full results from two successful late-stage trials of its experimental chronic obstructive pulmonary disease (COPD) therapy, fueling expectations that the drug could generate...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSYK","IBBJ","BMED","IBBQ","MDTX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":8,"totalSize":200,"code":"91000000","status":"200"}]}}